Effect of evening primrose oil on monocyte chemotactic protein-1 and tumour necrosis factor-alpha levels during delayed hypersensitivity immune responses

Medical Science Research

Volumn 26, Issue 8, 1998, Pages 567-569

  Dirks, J ^a,b   Van Aswegen, C H ^a   Du Plessis, D J ^a   Snyman, J R ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b NONE   (South Africa)

Author keywords

Delayed hypersensitivity; Evening primrose oil; Monocyte chemotactic protein 1; Purified protein derivative; Tuberculin; Tumour necrosis factor

Indexed keywords

LEUKOTRIENE; MONOCYTE CHEMOTACTIC PROTEIN 1; PRIMROSE OIL; PROSTAGLANDIN; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA; VEGETABLE OIL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; FOREARM; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; INFLAMMATION; INTRADERMAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TUBERCULIN TEST;

OENOTHERA; PRIMULA;

EID: 0031689218     PISSN: 02698951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Purasiri P. Heys SD, Eremin O. Essential fatty acids and malignant diseases. EurJ Surg Oncol 1994; 20:603-606.
2. Purasiri P, Ashby J. Heys SD, ERemin O. Effect of essential fatty acids on natural cytotoxicity in patients with colorectal cancer. Eur J Surg Oncol 1995:21:254-260.
3. Hauben M. Evening primrose oil in the treatment of rheumatoid arthritis. Ann Pharmacother 1994; 28:973.
4. Horribin DF, Evening primrose oil and atopic eczema. Lancet 1995; 345:260-261.
5. Hussain ST. Roots B. Effects of essential fatty acids deficiency and immunopathological stresses on blood brain barriers (B-BB) in Lewis rats. Biochem Sue Trans 1994; 22:3385.
6. Goldfien A. Premenstrual syndrome. Curr Ther Endochronol Met 1994:5:219-222.
7. Das UN. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Pmstagland Leukotr Essent Fatty Acids 1995; 52:387-391.
8. Dirks J, van Aswegen CH and du Plessis DJ. Cytokine levels affected by gamma-linolenic acid. Prostaglandins, Leukotrienes. and Essential Fatty Acids 1997; in press.
9. Hale K. Tuberculin skin test, proper technique and interpretation. Postgrad Med J 1985; 77:252-253.
10. Snider DE. Bacille Calmette-Guérin vaccination and tuberculin skin test. JAMA 1985; 253:3438-3439.
11. MacPhee MJ, Gordon J, Christen NV, SancheJ.-Cantu L. Rode HH. Cells recovered from human DTH reactions: phenotype and functional analysis. Cell Immunol 1993; 151:80-96.
12. Chu CQ, Field M, Andrew E, Haskard D, Feldmann M, Maini RN. Detection of cytokines at the site of tuberculin-induced delayed-type hypersensitivity in man. Clin Exp Immunol 1992: 90:552-529.
13. Huffnagle GB, Strieter RM, Standiford TJ, McDonald RA. Burdick D, Kunkel SL, et ul. The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J Immunol 1995; 155:4790-4797.
14. Standiford TJ, Kunkel SL, Phan SH, Rollins BJ, Strieter RM. Alveolar macrophage-derived cytokines induced monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Rial Chem 1991; 266:9912-9918.
15. Snyman JR. Meyer EC. Schoeman HS. Cimetide as modulator of the cell-mediated immune response in vivo using the tuberculin skin test as parameter. Br J Clin Pharmacol 1990; 29:257-260.
16. Snyman JR. Jacyk WK, Lizamore DJ. Sommers DeK. Dapsone as an immunomodulator in vivo using the tuberculin skin test as parameter. Clin Drug Invest 1995: 10:179-182.
17. Calder PC. Effects of fatty acids and dietary lipids on cells of the immune system. Proc Nutr Soc 1996; 55:127-150.
18. Jocks T, Zahner G, Freudenberg J, Wolf G, Thaiss F, Helmchen U, et al. Prostaglandin E ( l ) reduces the glomerular mRNA expression of monocyte chemotactic protein-1 in anti-thymocyte antibody-induced glomerular injury. J Am Soc Nephrol 1996: 7:897-905.
19. Locati M, Lamorte G, Luini W, Introna M, Bernsconi S, Mantovani A, et al. Inhibition of monocyte chemotaxis to C-C chemokines by antisense oligonucleotide for cytosolic phospholipase A2. J Biol Chem 1996:271:6010-6016.
20. Internet: http://www.skynet.co.uk/tsc/epo.htmml
21. Seibert K ei al. Specificity of expression and effect of eicosanoid mediators in normal physiological and human diseases. FASEB J 1995; 9:1051-1058.
22. Holt/man MJ, Zhang V. Hussain H, Roswit WT, Wilson JD. Prostaglandin H synthase and lipoxygenase gene in the epithelial cell barrier. Ann NYAcad Sci 1994; 744:58-77.
23. Herschman HR. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev 1994; 13:241-256.